Clinical trial Recruiting at 1 site Interventional

Thumb-base joint replacement for osteoarthritis

Official title: TRACE - A Single Arm Trial of Thumb Base Replacement Arthroplasty for Osteoarthritis Compared to External Controls

Run by Karolinska Institutet · NCT07178223 · Data updated 2026-11-12

This trial tries replacing the thumb-base (CMC-1) joint with a prosthesis to reduce pain and improve hand strength in people with thumb-base osteoarthritis who have not had enough relief from non-surgical care.

Quick facts

Study typeInterventional
SexAll
Enrollment90 (estimated)
SponsorKarolinska Institutet
Academic / other
Locations1 site (Stockholm)
StatusRecruiting
StartedAugust 1, 2025
Main results expectedDecember 31, 2038
Study endsDecember 31, 2038
Registry record updatedSeptember 23, 2025
Trial IDNCT07178223 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with symptomatic thumb-base (CMC-1) osteoarthritis Eaton class 1–3 who have pain on palpation or a positive grinding test and who are suitable for prosthetic cup placement are ideal candidates.

Probably not a fit

Patients with rheumatoid arthritis, active hand/wrist infection, gout or pseudogout in the hand, Eaton class 4 disease, severe trapezium deformity preventing cup placement, recent intra-articular steroid injection, chronic centralized pain, or inability to comply with follow-up are unlikely to benefit or are excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional trial offers total joint arthroplasty (prosthetic replacement) of the first carpometacarpal (CMC-1) joint as an alternative to non-implant surgeries for symptomatic thumb-base osteoarthritis. Eligible adults have radiographic Eaton class 1–3 disease and clinical pain on palpation or provocation, while patients with rheumatoid arthritis, active infection, gout/pseudogout, recent intra-articular steroid injection, Eaton class 4, or severe trapezium deformity preventing cup placement are excluded. Procedures are performed at the Hand Surgery Clinic, Södersjukhuset (Karolinska sponsor) and participants are followed with a postoperative protocol to record pain, function, recovery time, and complications. The trial aims to add comparative outcome and safety data to earlier reports suggesting quicker recovery and preserved strength after prosthetic arthroplasty.

Why it matters

Potential benefit: If successful, prosthetic thumb-base replacement could reduce pain during hand loading, improve grip strength, and speed functional recovery compared with current non-implant surgeries.

How similar studies have gone: Small early studies and case series have shown promising short-term pain relief and faster recovery with CMC-1 arthroplasty, but robust long-term comparative data are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Osteoarthritis in the thumb base. Radiological Eaton class 1-3 (Ladd et al. 2015).
* Clinical signs of thumb base osteoarthritis: pain at palpation of the CMC-1 joint and pain during provocation/grinding test.

The inclusion criteria are identical to those of the control population.

Exclusion Criteria:

* Rheumatoid arthritis.
* Ongoing infection in the hand or wrist.
* History of gout or pseudogout in the hand.
* Inability to co-operate with the follow-up protocol (language difficulties, severe psychiatric disorder, cognitive impairment, drug addiction).
* Chronic pain syndrome / centralized pain.
* Intra-articular corticosteroid injection in the affected joint within 3 months. -Eaton Littler class 4 (symptomatic STT joint osteoarthritis).

The previously described exclusion criteria are identical to those of the control population. In addition patients with severe deformation of the trapezium, to the extent that it is not possible to place a prosthetic cup, will be excluded.

Where it's running

  • Handkirurgiska kliniken Södersjukhuset
    Stockholm, Sweden
    Recruiting

Study contacts

  • Principal investigator: Maria Wilcke, Associate professor — Karolinska Institutet
  • Study coordinator: Maria Wilcke, MD, Associate professor
  • Email: maria.wilcke@ki.se
  • Phone: +4681236022

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.